Company profile
Health Advance Inc.
OTC: HADV · Healthcare · Medical - Pharmaceuticals
#1161 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ 17GM —SS 30
v0.1 · 25/100 weight · pillars only
↑ listing tenure, Altman-Z · ↓ 3-yr revenue growth, Piotroski F
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$29.5k
Employees
3
as of 2026-08-29
Market cap
$32.2k
as of 2026-08-29
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02016
Net income-$29.5k-$29.5k2016
Operating income-$262.8k-$262.8k2013
Total assets$0$02016
Liabilities$159.4k$159.4k2016
Equity-$159.4k-$159.4k2016
Revenue trend
FY2012 – FY2016 · USD
FY12
FY13
FY14
FY16
FY16
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Health Advance Inc.’s revenue?
Health Advance Inc. booked $0 in FY2016 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Bright Green Corporation——Wellness Matrix Group, Inc.——THC Therapeutics, Inc.——Transnational Cannabis Ltd.——Spencer Pharmaceutical Inc.——Pazoo, Inc.——Neighbors
Clark →Key facts
CEOLarry McLachlin
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersLas Vegas, NV
ExchangeOTC: HADV
Employees3
IPO date2012-09-25
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.